Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We then assessed whether vitamin D deficiency (≤20 ng/mL vs. >20 ng/mL) was associated with the need for organ support.

Source: 3.2. Association Between Vitamin D Status and Organ Support Requirements in SAE Patients. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

If sedation could not be safely interrupted, these patients were excluded from the primary GCS-based SAE definition, as persistent deep sedation confounds mental status evaluation.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Admission 25-Hydroxyvitamin D Deficiency Is Associated with Poor Outcomes in ICU Patients with Sepsis-Associated Encephalopathy (SAE)

Study design awaiting verification · Journal of Clinical Medicine · 2026

Original publication title

Admission 25-Hydroxyvitamin D Deficiency Is Associated with Poor Outcomes in ICU Patients with Sepsis-Associated Encephalopathy (SAE)

Yajun Qian; Chen Qu; Hui Qi; Ying Xu

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background:

Sepsis-associated encephalopathy (SAE) is a serious complication affecting septic patients and significantly increases mortality. Serum 25-hydroxyvitamin D (vitamin D) deficiency is prevalent in critical illness, but its relationship with SAE prognosis remains unclear.

Methods:

This retrospective cohort study enrolled SAE patients at Nanjing Drum Tower Hospital (January 2023: June 2024). Vitamin D levels were measured within 24 h of ICU admission with insufficiency and deficiency defined as ≤30 ng/mL and ≤20 ng/mL, respectively. Demographics, severity scores, laboratory parameters, organ support, and 90-day mortality were collected. Statistical analyses included Mann: Whitney U/t-tests, Spearman’s correlation, multivariate logistic regression, and ROC analysis.

Results:

Among 346 sepsis patients, 47 met SAE criteria. Vitamin D insufficiency affected 97.9% (46/47) of SAE patients, with 85.1% (40/47) being deficient. Ninety-day mortality was 25.5% (12/47). Non-survivors had significantly lower vitamin D levels than survivors (median 10.15 vs. 12.83 ng/mL, p = 0.010). Multivariate analysis identified higher APACHE II score (OR 1.164, 95% CI 1.042 to 1.300; p = 0.007) and lower vitamin D level (OR 0.758, 95% CI 0.603 to 0.954; p = 0.018) as independent predictors of 90-day mortality. Combining APACHE II score and vitamin D provided excellent predictive value (AUC 0.886). Vitamin D levels correlated negatively with IL-6 (rho = −0.293, p = 0.045) and vasopressor use (rho = −0.410, p = 0.004).

Conclusions:

Vitamin D insufficiency is nearly universal in SAE patients. Lower admission vitamin D levels independently predict 90-day mortality and enhance the predictive power of APACHE II. Vitamin D levels were negatively correlated with IL-6, suggesting a potential relationship with inflammation, but causality and clinical significance require further investigation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Sepsis-associated encephalopathy (SAE) is a serious complication affecting septic patients and significantly increases mortality. Serum 25-hydroxyvitamin D (vitamin D) deficiency is prevalent in critical illness, but its relationship with SAE prognosis remains unclear.

Source: Background

Abstract: Results

Among 346 sepsis patients, 47 met SAE criteria. Vitamin D insufficiency affected 97.9% (46/47) of SAE patients, with 85.1% (40/47) being deficient. Ninety-day mortality was 25.5% (12/47). Non-survivors had significantly lower vitamin D levels than survivors (median 10.15 vs. 12.83 ng/mL, p = 0.010). Multivariate analysis identified higher APACHE II score (OR 1.164, 95% CI 1.042 to 1.300; p = 0.007) and lower vitamin D level (OR 0.758, 95% CI 0.603 to 0.954; p = 0.018) as independent predictors of 90-day mortality. Combining APACHE II score and vitamin D provided excellent predictive value (AUC 0.886). Vitamin D levels correlated negatively with IL-6 (rho = −0.293, p = 0.045) and vasopressor use (rho = −0.410, p = 0.004).

Source: Results

Abstract: Conclusions

Vitamin D insufficiency is nearly universal in SAE patients. Lower admission vitamin D levels independently predict 90-day mortality and enhance the predictive power of APACHE II. Vitamin D levels were negatively correlated with IL-6, suggesting a potential relationship with inflammation, but causality and clinical significance require further investigation.

Source: Conclusions
Authors’ abstract

Background:

Sepsis-associated encephalopathy (SAE) is a serious complication affecting septic patients and significantly increases mortality. Serum 25-hydroxyvitamin D (vitamin D) deficiency is prevalent in critical illness, but its relationship with SAE prognosis remains unclear.

Methods:

This retrospective cohort study enrolled SAE patients at Nanjing Drum Tower Hospital (January 2023: June 2024). Vitamin D levels were measured within 24 h of ICU admission with insufficiency and deficiency defined as ≤30 ng/mL and ≤20 ng/mL, respectively. Demographics, severity scores, laboratory parameters, organ support, and 90-day mortality were collected. Statistical analyses included Mann: Whitney U/t-tests, Spearman’s correlation, multivariate logistic regression, and ROC analysis.

Results:

Among 346 sepsis patients, 47 met SAE criteria. Vitamin D insufficiency affected 97.9% (46/47) of SAE patients, with 85.1% (40/47) being deficient. Ninety-day mortality was 25.5% (12/47). Non-survivors had significantly lower vitamin D levels than survivors (median 10.15 vs. 12.83 ng/mL, p = 0.010). Multivariate analysis identified higher APACHE II score (OR 1.164, 95% CI 1.042 to 1.300; p = 0.007) and lower vitamin D level (OR 0.758, 95% CI 0.603 to 0.954; p = 0.018) as independent predictors of 90-day mortality. Combining APACHE II score and vitamin D provided excellent predictive value (AUC 0.886). Vitamin D levels correlated negatively with IL-6 (rho = −0.293, p = 0.045) and vasopressor use (rho = −0.410, p = 0.004).

Conclusions:

Vitamin D insufficiency is nearly universal in SAE patients. Lower admission vitamin D levels independently predict 90-day mortality and enhance the predictive power of APACHE II. Vitamin D levels were negatively correlated with IL-6, suggesting a potential relationship with inflammation, but causality and clinical significance require further investigation.

Publication and source details

Original title: Admission 25-Hydroxyvitamin D Deficiency Is Associated with Poor Outcomes in ICU Patients with Sepsis-Associated Encephalopathy (SAE)

Yajun Qian; Chen Qu; Hui Qi; Ying Xu

Journal of Clinical Medicine · 2026

* Correspondence: qihuizhang@126.com (H.Q.); xuying.0110@163.com (Y.X.)
†

These authors contributed equally to this work.

© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. National Natural Science Foundation of Chinahttps://ror.org/01h0zpd94 82372165Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project2025ZD01902800Medical Science and technology development Foundation, Nanjing Department of HealthZKX24018YKK21083This research was funded by the National Natural Science Foundation of China, grant number 82372165; the Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, grant number 2025ZD01902800; and the Key Project supported by the Medical Science and technology development Foundation, Nanjing Department of Health, grant number ZKX24018 and YKK21083.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-09T20:17:33.159419+00:00

DOI: 10.3390/jcm15145466 · PMC13412509